相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activity of Eravacycline against Escherichia coli Clinical Isolates Collected from US Veterans in 2011 in Relation to Coresistance Phenotype and Sequence Type 131 Genotype
James R. Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Eravacycline (TP-434) Is Active In Vitro against Biofilms Formed by Uropathogenic Escherichia coli
Trudy H. Grossman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Eravacycline (TP-434) Is Efficacious in Animal Models of Infection
Trudy H. Grossman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
New antibiotics and antimicrobial combination therapy for the treatment of gram-negative bacterial infections
Matteo Bassetti et al.
CURRENT OPINION IN CRITICAL CARE (2015)
Healthcare-associated infections, infection control and the potential of new antibiotics in development in the USA
Alpesh N. Amin et al.
FUTURE MICROBIOLOGY (2015)
A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens
Karen Bush
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Investigational Agents for the Treatment of Gram-Negative Bacterial Infections: A Reality Check
Karen Bush
ACS INFECTIOUS DISEASES (2015)
Activity of Eravacycline against Enterobacteriaceae and Acinetobacter baumannii, Including Multidrug-Resistant Isolates, from New York City
Marie Abdallah et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
In Vitro Susceptibility of Characterized β-Lactamase-Producing Strains Tested with Avibactam Combinations
Henry Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Phase 2, Randomized, Double-Blind Study of the Efficacy and Safety of Two Dose Regimens of Eravacycline versus Ertapenem for Adult Community-Acquired Complicated Intra-Abdominal Infections
Joseph S. Solomkin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine US Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
The Global Challenge of Carbapenem-Resistant Enterobacteriaceae in Transplant Recipients and Patients With Hematologic Malignancies
Michael J. Satlin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Discovery and development of new antibacterial agents targeting Gram-negative bacteria in the era of pandrug resistance: is the future promising?
Malcolm G. P. Page et al.
CURRENT OPINION IN PHARMACOLOGY (2014)
Challenges in the Management of Infections due to Carbapenem-Resistant Enterobacteriaceae
Dimitri M. Drekonja et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2014)
Antibacterial Activity of Eravacycline (TP-434), a Novel Fluorocycline, against Hospital and Community Pathogens
J. A. Sutcliffe et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Detection systems for carbapenemase gene identification should include the SME serine carbapenemase
Karen Bush et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Target- and Resistance-Based Mechanistic Studies with TP-434, a Novel Fluorocycline Antibiotic
Trudy H. Grossman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Rapid Detection of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2012)
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Robert J. Guidos et al.
CLINICAL INFECTIOUS DISEASES (2011)
Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in Detroit
Marilynn R. Fairfax et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Multiplex PCR for detection of acquired carbapenemase genes
Laurent Poirel et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2011)
Molecular Epidemiology of CTX-M-Producing Escherichia coli Isolates at a Tertiary Medical Center in Western Pennsylvania
Hanna E. Sidjabat et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing β-lactamases
Anne Marie Queenan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States
K Lolans et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
H Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
SME-type carbapenem-hydrolyzing class A β-lactamases from geographically diverse Serratia marcescens strains
AM Queenan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
